Cart
sales@molnova.com
FHD-286
CAS No. 2671128-05-3
FHD-286( —— )
Catalog No. M28880 CAS No. 2671128-05-3
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 335 | Get Quote |
|
| 10MG | 520 | Get Quote |
|
| 25MG | 840 | Get Quote |
|
| 50MG | 1143 | Get Quote |
|
| 100MG | 1521 | Get Quote |
|
| 500MG | 3087 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFHD-286
-
NoteResearch use only, not for human use.
-
Brief DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
In Vitro——
-
In VivoAnimal Model:B16F10 tumor-bearing miceDosage:1.5 mg/kg Administration:Oral administration; for 10 days Result:Increased in IFNγ and Th1-type chemokine CXCL10 levels.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2671128-05-3
-
Formula Weight562.66
-
Molecular FormulaC24H30N6O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (444.32 mM)
-
SMILESC[C@H](C1)O[C@@H](C)CN1c1cccc(-c2csc(NC([C@H](COC)NC(c(cc3)cn3S(C)(=O)=O)=O)=O)n2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiao J, et al. Identification of a Novel Specific Cucurbitadienol Synthase Allele in Siraitia grosvenorii Correlates with High Catalytic Efficiency. Molecules. 2019 Feb 11;24(3).
molnova catalog
related products
-
BET bromodomain inhi...
It is a BET bromodomain inhibitor.
-
PBRM1-BD2-IN-2
PBRM1-BD2-IN-2, a selective and cell-active inhibitor of the polybromo-1 (PBRM1) bromodomain, exhibits binding affinity and inhibitory activity specifically targeting the PBRM1-BD2 domain, with Kd and IC50 values of 9.3 μM and 1.0 μM, respectively.
-
BRD4-BD1-IN-2
BRD4-BD1-IN-2 is a selective and potent BRD4-BD1 inhibitor with an IC50 value of 2.51 μM, exhibiting 20-fold greater inhibitory activity against BRD4-BD1 compared to BRD4-BD2.
